View in EDS HTML Full Text PDF Full Text

Repurposing Approved Drugs as Inhibitors of Kv7.1 and Nav1.8 to Treat Pitt Hopkins Syndrome.

Saved in:
Bibliographic Details
Title: Repurposing Approved Drugs as Inhibitors of Kv7.1 and Nav1.8 to Treat Pitt Hopkins Syndrome.
Authors: Ekins S; Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, North Carolina, 27606, USA. sean@collaborationspharma.com., Gerlach J; Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, North Carolina, 27606, USA., Zorn KM; Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, North Carolina, 27606, USA., Antonio BM; Icagen, Inc., 4222 Emperor Blvd, Durham, North Carolina, 27703, USA., Lin Z; Icagen, Inc., 4222 Emperor Blvd, Durham, North Carolina, 27703, USA., Gerlach A; Icagen, Inc., 4222 Emperor Blvd, Durham, North Carolina, 27703, USA.
Source: Pharmaceutical research [Pharm Res] 2019 Jul 22; Vol. 36 (9), pp. 137. Date of Electronic Publication: 2019 Jul 22.
Publication Type: Journal Article
Journal Info: Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 8406521 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-904X (Electronic) Linking ISSN: 07248741 NLM ISO Abbreviation: Pharm Res
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31332533
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Repurposing Approved Drugs as Inhibitors of K<subscript>v</subscript>7.1 and Na<subscript>v</subscript>1.8 to Treat Pitt Hopkins Syndrome.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ekins+S%22">Ekins S</searchLink>; Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, North Carolina, 27606, USA. sean@collaborationspharma.com.<br /><searchLink fieldCode="AU" term="%22Gerlach+J%22">Gerlach J</searchLink>; Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, North Carolina, 27606, USA.<br /><searchLink fieldCode="AU" term="%22Zorn+KM%22">Zorn KM</searchLink>; Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, North Carolina, 27606, USA.<br /><searchLink fieldCode="AU" term="%22Antonio+BM%22">Antonio BM</searchLink>; Icagen, Inc., 4222 Emperor Blvd, Durham, North Carolina, 27703, USA.<br /><searchLink fieldCode="AU" term="%22Lin+Z%22">Lin Z</searchLink>; Icagen, Inc., 4222 Emperor Blvd, Durham, North Carolina, 27703, USA.<br /><searchLink fieldCode="AU" term="%22Gerlach+A%22">Gerlach A</searchLink>; Icagen, Inc., 4222 Emperor Blvd, Durham, North Carolina, 27703, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228406521%22">Pharmaceutical research</searchLink> [Pharm Res] 2019 Jul 22; Vol. 36 (9), pp. 137. <i>Date of Electronic Publication: </i>2019 Jul 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%2FPlenum+Publishers%22">Kluwer Academic/Plenum Publishers </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8406521 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-904X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2207248741%22">07248741 </searchLink><i>NLM ISO Abbreviation: </i>Pharm Res
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31332533
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s11095-019-2671-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 137
    Titles:
      – TitleFull: Repurposing Approved Drugs as Inhibitors of Kv7.1 and Nav1.8 to Treat Pitt Hopkins Syndrome.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ekins S
      – PersonEntity:
          Name:
            NameFull: Gerlach J
      – PersonEntity:
          Name:
            NameFull: Zorn KM
      – PersonEntity:
          Name:
            NameFull: Antonio BM
      – PersonEntity:
          Name:
            NameFull: Lin Z
      – PersonEntity:
          Name:
            NameFull: Gerlach A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 07
              Text: 2019 Jul 22
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1573-904X
          Numbering:
            – Type: volume
              Value: 36
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Pharmaceutical research
              Type: main
ResultId 1